10 Firms Fall Amid Disappointing Earnings Performance

4. Oscar Health Inc. (NYSE:OSCR)

Health insurance firm Oscar Health saw an 8.78 percent decline in its stock price on Tuesday to finish at $15.28 each after reporting mixed earnings performance in the fourth quarter of 2024.

In three months ending December 2024, Oscar Health said net loss expanded to $153 million from the $150 million registered in the same period a year ago. However, it swung to a net income of $25.4 million in full-year 2024 from a $271 million net loss in 2023.

Revenues for both the fourth quarter and full year came in higher by 67 percent and 57 percent, respectively.

For this year, Oscar Health said it targets to book between $11.2 billion and $11.3 billion in total revenues, or an increase of 23 percent year-on-year.